Fresenius Medical Care AG KGaA SG&A Expenses 2010-2024 | FMS
Fresenius Medical Care AG KGaA annual/quarterly sg&a expenses history and growth rate from 2010 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
- Fresenius Medical Care AG KGaA sg&a expenses for the quarter ending December 31, 2024 were $0.896B, a 1.55% decline year-over-year.
- Fresenius Medical Care AG KGaA sg&a expenses for the twelve months ending December 31, 2024 were $3.401B, a 1.69% decline year-over-year.
- Fresenius Medical Care AG KGaA annual sg&a expenses for 2024 were $3.401B, a 1.69% decline from 2023.
- Fresenius Medical Care AG KGaA annual sg&a expenses for 2023 were $3.459B, a 13.24% decline from 2022.
- Fresenius Medical Care AG KGaA annual sg&a expenses for 2022 were $3.987B, a 8.86% increase from 2021.
| Fresenius Medical Care AG KGaA Annual SG&A Expenses (Millions of US $) |
|
|---|---|
| 2024 | $3,401 |
| 2023 | $3,459 |
| 2022 | $3,987 |
| 2021 | $3,663 |
| 2020 | $3,615 |
| 2019 | $3,428 |
| 2018 | $3,384 |
| 2017 | $4,044 |
| 2016 | $3,045 |
| 2015 | $2,896 |
| 2014 | $2,644 |
| 2013 | $2,383 |
| 2012 | $2,325 |
| 2011 | $2,366 |
| 2010 | $2,124 |
| 2009 | $1,982 |
| Fresenius Medical Care AG KGaA Quarterly SG&A Expenses (Millions of US $) |
|
|---|---|
| 2024-12-31 | $896 |
| 2024-09-30 | $831 |
| 2024-06-30 | $831 |
| 2024-03-31 | $842 |
| 2023-12-31 | $911 |
| 2023-09-30 | $864 |
| 2023-06-30 | $845 |
| 2023-03-31 | $840 |
| 2022-12-31 | $981 |
| 2022-09-30 | $997 |
| 2022-06-30 | $1,032 |
| 2022-03-31 | $978 |
| 2021-12-31 | $943 |
| 2021-09-30 | $862 |
| 2021-06-30 | $1,000 |
| 2021-03-31 | $858 |
| 2020-12-31 | $1,020 |
| 2020-09-30 | $839 |
| 2020-06-30 | $813 |
| 2020-03-31 | $943 |
| 2019-12-31 | $908 |
| 2019-09-30 | $806 |
| 2019-06-30 | $902 |
| 2019-03-31 | $812 |
| 2018-12-31 | $817 |
| 2018-09-30 | $864 |
| 2018-06-30 | $853 |
| 2018-03-31 | $850 |
| 2017-12-31 | $1,129 |
| 2017-09-30 | $942 |
| 2017-06-30 | $990 |
| 2017-03-31 | $984 |
| 2016-12-31 | $767 |
| 2016-09-30 | $787 |
| 2016-06-30 | $732 |
| 2016-03-31 | $758 |
| 2015-12-31 | $776 |
| 2015-09-30 | $742 |
| 2015-06-30 | $723 |
| 2015-03-31 | $655 |
| 2014-12-31 | $720 |
| 2014-09-30 | $671 |
| 2014-06-30 | $630 |
| 2014-03-31 | $620 |
| 2013-12-31 | $611 |
| 2013-09-30 | $585 |
| 2013-06-30 | $595 |
| 2013-03-31 | $592 |
| 2012-12-31 | $710 |
| 2012-09-30 | $522 |
| 2012-06-30 | $540 |
| 2012-03-31 | $553 |
| 2011-12-31 | $602 |
| 2011-09-30 | $598 |
| 2011-06-30 | $594 |
| 2011-03-31 | $571 |
| 2010-12-31 | $543 |
| 2010-09-30 | $538 |
| 2010-06-30 | $526 |
| 2010-03-31 | $518 |
| 2009-12-31 | $539 |
| 2009-09-30 | $505 |
| 2009-06-30 | $495 |
| 2009-03-31 | $444 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $14.612B | $20.627B |
| Fresenius Medical Care AG & Co. KGaA is one of the largest integrated providers of products and services for individuals undergoing dialysis. Fresenius Medical provides products and services across the entire dialysis value chain throughout the World. Fresenius Medical manufactures a variety of durable medical devices used in the treatment of End Stage Renal Disease (ESRD). Devices like Hemodialysis Machines, Peritoneal Dialysis Machines, Granuflo Concentrate Mixing Tanks and monitoring devices like the Crit-line platform are included in the company's product pipeline. The company primarily operates in - The Health Care Services segment: Consists of the company's Dialysis Services and the Care-Coordination (non-dialysis laboratory services). The Health Care Products segment: Comprises of the company's Dialysis machines, dialyzers, dialysis solutions, hemodialysis concentrates, bloodline systems, water treatment systems, dialysis drugs and other medical products.. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $187.725B | 22.76 |
| Intuitive Surgical (ISRG) | United States | $176.405B | 80.93 |
| Alcon (ALC) | Switzerland | $46.824B | 31.12 |
| Edwards Lifesciences (EW) | United States | $42.608B | 27.66 |
| IDEXX Laboratories (IDXX) | United States | $34.032B | 39.36 |
| IQVIA Holdings (IQV) | United States | $31.084B | 17.20 |
| DexCom (DXCM) | United States | $26.777B | 41.39 |
| Mettler-Toledo (MTD) | United States | $24.611B | 28.69 |
| STERIS (STE) | Ireland | $22.269B | 25.47 |
| Waters (WAT) | United States | $21.897B | 31.05 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.380B | 0.00 |
| Hologic (HOLX) | United States | $13.861B | 14.96 |
| Sysmex ADR (SSMXY) | Japan | $11.941B | 37.44 |
| Penumbra (PEN) | United States | $10.300B | 93.17 |
| Globus Medical (GMED) | United States | $10.068B | 23.31 |
| Masimo (MASI) | United States | $9.002B | 37.78 |
| Teleflex (TFX) | United States | $6.407B | 9.86 |
| Glaukos (GKOS) | United States | $5.567B | 0.00 |
| Integer Holdings (ITGR) | United States | $3.967B | 22.27 |
| PROCEPT BioRobotics (PRCT) | United States | $3.194B | 0.00 |
| Veracyte (VCYT) | United States | $2.311B | 41.76 |
| TransMedics (TMDX) | United States | $2.265B | 66.61 |
| Nihon Kohden (NHNKY) | Japan | $2.205B | 12.06 |
| LivaNova (LIVN) | United Kingdom | $2.135B | 12.96 |
| Elekta AB (EKTAY) | Sweden | $1.995B | 17.93 |
| Integra LifeSciences Holdings (IART) | United States | $1.698B | 8.59 |
| Alphatec Holdings (ATEC) | United States | $1.462B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.274B | 0.00 |
| OPKO Health (OPK) | United States | $1.115B | 0.00 |
| Paragon 28 (FNA) | United States | $1.096B | 0.00 |
| Artivion (AORT) | United States | $1.034B | 98.32 |
| RxSight (RXST) | United States | $1.022B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.990B | 0.00 |
| AxoGen (AXGN) | United States | $0.820B | 0.00 |
| IRadimed (IRMD) | United States | $0.667B | 34.99 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.659B | 10.61 |
| Mesa Laboratories (MLAB) | United States | $0.645B | 14.09 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.636B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.598B | 0.00 |
| SiBone (SIBN) | United States | $0.596B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.531B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.525B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.425B | 0.00 |
| NeuroPace (NPCE) | United States | $0.400B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.380B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.351B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.347B | 7.37 |
| ClearPoint Neuro (CLPT) | United States | $0.329B | 0.00 |
| CVRx (CVRX) | United States | $0.318B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.313B | 16.73 |
| Nevro (NVRO) | United States | $0.224B | 0.00 |
| Inogen (INGN) | United States | $0.192B | 0.00 |
| Accuray (ARAY) | United States | $0.184B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.177B | 0.00 |
| LENSAR (LNSR) | United States | $0.166B | 0.00 |
| 908 Devices (MASS) | United States | $0.158B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.147B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.135B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.131B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.123B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.117B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.114B | 0.00 |
| Neuronetics (STIM) | United States | $0.112B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.104B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.087B | 0.00 |
| InspireMD (NSPR) | Israel | $0.080B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.078B | 11.82 |
| EDAP TMS S.A (EDAP) | France | $0.073B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.057B | 0.00 |
| Hyperfine (HYPR) | United States | $0.056B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.052B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.046B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.039B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.034B | 0.00 | |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Spectral AI (MDAI) | United States | $0.027B | 0.00 |
| Envoy Medical (COCH) | United States | $0.026B | 0.00 |
| DarioHealth (DRIO) | United States | $0.025B | 0.00 |
| NexGel (NXGL) | United States | $0.023B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.018B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.008B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |